相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure characterization and hypoglycemic effects of dual modified resistant starch from indica rice starch
Ying Zhou et al.
CARBOHYDRATE POLYMERS (2014)
Mineralized cyclodextrin nanoparticles for sustained protein delivery
Maharajan Sivasubramanian et al.
CARBOHYDRATE POLYMERS (2013)
Carboxymethyl Dextran-Cyclodextrin Conjugate as the Carrier of Doxorubicin
Maharajan Sivasubramanian et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2013)
Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity
Nian Gong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Long acting hyaluronate - exendin 4 conjugate for the treatment of type 2 diabetes
Ji-Hyun Kong et al.
BIOMATERIALS (2010)
Hydrophobic pharmaceuticals mediated self-assembly of β-cyclodextrin containing hydrophilic copolymers: Novel chemical responsive nano-vehicles for drug delivery
Jianxiang Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2010)
The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics
Su Young Chae et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs
Su Young Chae et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Protein-Release Behavior of Self-Assembled PEG-β-Cyclodextrin/PEG-Cholesterol Hydrogels
Frank van de Manakker et al.
ADVANCED FUNCTIONAL MATERIALS (2009)
Preparation and Structural, Biochemical, and Pharmaceutical Characterizations of Bile Acid-Modified Long-Acting Exendin-4 Derivatives
Sohee Son et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system
Taishi Higashi et al.
BIOMATERIALS (2008)
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes
Dennis Kim et al.
DIABETES CARE (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs
L Simonsen et al.
DIABETOLOGIA (2006)
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
分享论文
